ONYX PHARMACEUTICALS INC Debt Instrument, Convertible, Conversion Ratio (Deprecated 2013-01-31)
ONYX PHARMACEUTICALS INC reported Debt Instrument, Convertible, Conversion Ratio (Deprecated 2013-01-31) of 25.221 shares for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentConvertibleConversionRatio · last filed 2012-08-06
- ONYX PHARMACEUTICALS INC debt instrument, convertible, conversion ratio (deprecated 2013-01-31) for the quarter ending 2012-03-31 was 2522.07%.
- ONYX PHARMACEUTICALS INC debt instrument, convertible, conversion ratio (deprecated 2013-01-31) for fiscal 2011 was 2522.07%.
pure
| Period end | Debt Instrument, Convertible, Conversion Ratio (Deprecated 2013-01-31) 3 month | Debt Instrument, Convertible, Conversion Ratio (Deprecated 2013-01-31) 6 month | Debt Instrument, Convertible, Conversion Ratio (Deprecated 2013-01-31) 9 month | Debt Instrument, Convertible, Conversion Ratio (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | 2522.07% 10-Q · filed 2012-05-04 | |||
| 2011-12-31 | 2522.07% 10-K · filed 2012-02-27 | |||
| 2011-09-30 | 2522.07% 10-Q · filed 2011-11-03 | |||
| 2011-06-30 | 2522.07% 10-Q · filed 2011-08-09 |
shares
| Period end | Debt Instrument, Convertible, Conversion Ratio (Deprecated 2013-01-31) 6 month |
|---|---|
| 2012-06-30 | 25.22 shares 10-Q · filed 2012-08-06 |